Table 4.

Hospitalisation and steroid usage among children and adolescents with IBD in PS matched cohort.

	South Asian	Caucasian	p-value
Hospitalisation at diagnosis
Hospitalisation at diagnosis
CD	23 [46%]	26 [24%]	0.006
UC/IBD-U	22 [38%]	37 [39%]	0.94
Steroid use post-induction in CD
18 mo event free survival	40 [85%]	93 [92%]	0.19
Time to post induction CS usagea	33 [17–38]	34 [18–57]	0.13
Steroid use post-induction in UC/IBD-U
18 mo event free survival	39 [70%]	63 [72%]	0.72
Time to post induction CS usagea	24 [15–43]	39 [18–50]	0.49

Values are presented as n [%].

CD, Crohn’s disease; UC, ulcerative colitis; IBD-U, inflammatory bowel disease unclassified; PS, propensity score; mo, months; CS, corticosteroid.

^aMedian [interquartile range] in weeks.